A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Kivu Bioscience Inc.
Kivu Bioscience Inc.
Eli Lilly and Company
Parabilis Medicines, Inc.
Actuate Therapeutics Inc.
Hoffmann-La Roche
Erasca, Inc.
QBiotics Group Limited
ViroMissile, Inc.
Angiex, Inc.
MacroGenics
Cogent Biosciences, Inc.
Solve Therapeutics
Ocellaris Pharma, Inc.
Transgene
Turning Point Therapeutics, Inc.
IDRx Inc. - A GSK Company
Kazia Therapeutics Limited
Sensei Biotherapeutics, Inc.
NextPoint Therapeutics, Inc.
Hutchmed
Elevation Oncology
IGM Biosciences, Inc.
Immunophotonics, Inc.
Deciphera Pharmaceuticals, LLC
Immodulon Therapeutics Ltd
GI Innovation, Inc.
Mundipharma Research Limited
Taiho Pharmaceutical Co., Ltd.
Sumitomo Pharma America, Inc.
NantCell, Inc.
Astex Pharmaceuticals, Inc.
ImmunityBio, Inc.
ImmunityBio, Inc.
ImmunityBio, Inc.
Adaptimmune
Ipsen
OncoResponse, Inc.
pharmaand GmbH
Bayer
Nektar Therapeutics
AB Science
Quadriga Biosciences, Inc.
Amgen
Boston Scientific Corporation
Boston Scientific Corporation
GlaxoSmithKline
NKGen Biotech, Inc.
Amgen
AB Science
SpeciCare